Aehr Test Systems’ Revenue Falls to $11M, AI Hyperscaler Deal Triggers 17% Stock Drop

AEHRAEHR

Aehr Test Systems reported revenue declined to $11 million from $13.1 million, and its stock dropped over 17% after an AI hyperscaler deal on October 7. The company’s FOX systems and WaferPaks are in evaluation with an AI processor supplier, setting it up for high-margin orders by fiscal 2027.

1. Analyst Outlook Remains Steady

Analysts continue to view Aehr Test Systems favorably, as consensus price targets have held steady around the high twenties over the past year. This stability reflects confidence in the company’s technology roadmap and its positioning within the semiconductor test equipment market. Notably, opinions diverge on near-term guidance; one firm reduced its target in response to softer order intake and the absence of explicit revenue guidance, while others maintain a bullish stance based on long-term growth potential in AI and data center applications.

2. Recent Financial Results and Order Trends

In its latest quarterly report, Aehr Test Systems recorded revenue of 11 million dollars, down from 13.1 million dollars a year earlier. Despite this decline, management highlighted continued traction in AI-related bookings, including several smaller orders from major hyperscalers. The company experienced a notable stock reaction after announcing an evaluation agreement with a leading AI processor supplier, underscoring both the market’s sensitivity to delivery timing and the strategic importance of these engagements for future revenue streams.

3. Technological Advantages and Future Prospects

Aehr’s FOX systems and WaferPak solutions are engineered to replace legacy burn-in processes with higher throughput and better energy efficiency. These high-margin offerings are in paid evaluation with multiple AI and data center customers, positioning the company to secure substantial purchase commitments by fiscal 2027. However, potential headwinds in adjacent markets—such as silicon carbide device testing—could introduce variability in order flow and margins during fiscal 2026. Investors should monitor updates on multi-year test tool contracts and guidance revisions at the next earnings release.

Sources

FB